18 Jan 2021 | 03:30 PM GMT
Past Meeting

DTx in Neurology

Participants:

Shrawan Patel General PartnerPharmStars VenturesInvestor & Accelerators
Investor & Accelerators
Shrawan Patel
General PartnerPharmStars Ventures
David Eichler President and Managing PartnerCobalt Ventures
David Eichler
President and Managing PartnerCobalt Ventures
George Brunner Exec Director, U.S. Vaccine MarketingMERCK &AMP AMP COOther
Other
George Brunner
Exec Director, U.S. Vaccine MarketingMERCK &AMP AMP CO
Jim O'Donoghue PresidentS3 Connected HealthProfessional Services
Professional Services
Jim O'Donoghue
PresidentS3 Connected Health
Laurent Morlet Sr. Director Therapeutic, R&D Business TechJohnson & JohnsonOther
Other
Laurent Morlet
Sr. Director Therapeutic, R&D Business TechJohnson & Johnson
Lina Behrens Head of Strategy & Content, Director HTSHLTH EuropeProfessional Services
Professional Services
Lina Behrens
Head of Strategy & Content, Director HTSHLTH Europe
Oliver Gassner Co-Founder & CEOHolofy Health
Oliver Gassner
Co-Founder & CEOHolofy Health
Quentin Le Masne Head, Solution Delivery, Digital HealthMerck GroupOther
Other
Quentin Le Masne
Head, Solution Delivery, Digital HealthMerck Group
Tim Juergens PartnerCrossroad BiotechInvestor & Accelerators
Investor & Accelerators
Tim Juergens
PartnerCrossroad Biotech
Varun Ramdevan Global Digital Partnerships LeadJohnson & Johnson InnovationOther
Other
Varun Ramdevan
Global Digital Partnerships LeadJohnson & Johnson Innovation
Vivian De Ruijter Senior AssociateIntuitive Ventures
Vivian De Ruijter
Senior AssociateIntuitive Ventures

About this Meeting

DTx in Neurology 

Join us at 10.30 am EDT

 

We have seen a flurry of activity in digital therapeutics in neurology - from being used in pediatrics [ADHD] to geriatrics [Alzheimer's, dementia] and across use cases such a cognition, stroke rehabilitation, motor symptom and tremor control, pain management, to list a few. Why is Neurology an area well suited to DTx interventions - lack of pharmacological treatment or more easily amenable to a tech intervention, or something else? What has been the industry perception and reception of DTx products for neurological indications?

About Us

HLTH Inc. is a dynamic community delivering unique value to the healthcare industry through a mix of unparalleled global events, inspirational content, and impact-driven initiatives.

Hyve Logo

USA Event Dates

2026 | HLTH: Nov 15 – 18 | Las Vegas | Register | Sponsor
2027 | ViVE: Mar 14 – 17 | Nashville | Be First to Know | Sponsor
2027 | HLTH: Oct 17 – 20 | Las Vegas, NV

Europe Event Dates

2027 | HLTH Europe: Jun 21 – 24 | Amsterdam | Sponsor
2028 | HLTH Europe: Jun 19 – 22 | Amsterdam

Important Notice on Hotel Scams

Any communication that claims to represent HLTH or any third party offering discounted hotel rooms or attendee lists is NOT AFFILIATED with HLTH and should be considered fraudulent. Please book your accommodations only through HLTH’s official channels to ensure authenticity and security.